Skip to content

Post-market study of Pipit-NC Balloon Dilatation Catheter

Post-market evaluation of safety & performance of Pipit-NC PTCA Balloon Dilatation Catheter in patients with stenotic coronary arteries during percutaneous coronary intervention - Pipit-NC PMCF Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056616
Enrollment
87
Registered
2023-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I209- Angina pectoris, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Sahajanand Medical Technologies Ltd. (SMT)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient must be at least 18 years of age 2. Patient or a legally authorized representative must provide written informed consent prior to any study related procedure 3. Patient must agree not to participate in any other clinical study during hospitalisation for the index procedure 4. Target lesion(s) can be treated with Pipit-NC PTCA Balloon Dilatation Catheter as per the current IFU.

Exclusion criteria

Exclusion criteria: Patient not meeting any of the above inclusion criteria

Design outcomes

Primary

MeasureTime frame
1. Device Success 2. Procedural successTimepoint: Baseline (From the start to end of the interventional procedure)

Secondary

MeasureTime frame
Individual procedural parameters - Coronary perforation - Coronary dissection - Coronary thrombosis - Clinically significant arrhythmias (requiring intervention)Timepoint: Up to end of PTCA procedure;Safety endpoints - All-cause mortality - Any MI - Any revascularizationTimepoint: Up to hospital discharge

Countries

India

Contacts

Public ContactDr Atul D Abhyankar

Shree B. D. Mehta Mahavir Heart Institute

atulda.abhyankar@gmail.com9824145738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026